company background image
CVET logo

Covetrus NasdaqGM:CVET Stock Report

Last Price

US$20.99

Market Cap

US$2.9b

7D

0.5%

1Y

5.6%

Updated

16 Oct, 2022

Data

Company Financials +

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

CVET Stock Overview

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. More details

CVET fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Covetrus, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Covetrus
Historical stock prices
Current Share PriceUS$20.99
52 Week HighUS$21.20
52 Week LowUS$13.39
Beta1.51
1 Month Change0.53%
3 Month Change0.91%
1 Year Change5.58%
3 Year Change107.00%
5 Year Changen/a
Change since IPO-50.02%

Recent News & Updates

Covetrus GAAP EPS of -$0.03 misses by $0.06, revenue of $1.22B in-line

Aug 04

Recent updates

Covetrus GAAP EPS of -$0.03 misses by $0.06, revenue of $1.22B in-line

Aug 04

Clayton, Dubilier & Rice/TPG Are Not Offering Fair Value To Covetrus Shareholders

Jun 02

Covetrus, Inc.'s (NASDAQ:CVET) Intrinsic Value Is Potentially 98% Above Its Share Price

May 02
Covetrus, Inc.'s (NASDAQ:CVET) Intrinsic Value Is Potentially 98% Above Its Share Price

Are Investors Undervaluing Covetrus, Inc. (NASDAQ:CVET) By 40%?

Jan 07
Are Investors Undervaluing Covetrus, Inc. (NASDAQ:CVET) By 40%?

We Think Covetrus (NASDAQ:CVET) Has A Fair Chunk Of Debt

Oct 21
We Think Covetrus (NASDAQ:CVET) Has A Fair Chunk Of Debt

An Intrinsic Calculation For Covetrus, Inc. (NASDAQ:CVET) Suggests It's 37% Undervalued

Sep 16
An Intrinsic Calculation For Covetrus, Inc. (NASDAQ:CVET) Suggests It's 37% Undervalued

Estimating The Intrinsic Value Of Covetrus, Inc. (NASDAQ:CVET)

May 31
Estimating The Intrinsic Value Of Covetrus, Inc. (NASDAQ:CVET)

Is Covetrus (NASDAQ:CVET) Using Too Much Debt?

May 05
Is Covetrus (NASDAQ:CVET) Using Too Much Debt?

Who Has Been Selling Covetrus, Inc. (NASDAQ:CVET) Shares?

Feb 26
Who Has Been Selling Covetrus, Inc. (NASDAQ:CVET) Shares?

We Think Covetrus (NASDAQ:CVET) Has A Fair Chunk Of Debt

Jan 22
We Think Covetrus (NASDAQ:CVET) Has A Fair Chunk Of Debt

Covetrus (NASDAQ:CVET) Shareholders Have Enjoyed An Impressive 106% Share Price Gain

Dec 18
Covetrus (NASDAQ:CVET) Shareholders Have Enjoyed An Impressive 106% Share Price Gain

Shareholder Returns

CVETUS HealthcareUS Market
7D0.5%-1.9%-0.3%
1Y5.6%-12.4%8.1%

Return vs Industry: CVET matched the US Healthcare industry which returned 4.9% over the past year.

Return vs Market: CVET exceeded the US Market which returned -25.8% over the past year.

Price Volatility

Is CVET's price volatile compared to industry and market?
CVET volatility
CVET Average Weekly Movement0.3%
Healthcare Industry Average Movement7.9%
Market Average Movement8.0%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market4.2%

Stable Share Price: CVET has not had significant price volatility in the past 3 months.

Volatility Over Time: CVET's weekly volatility has decreased from 6% to 0% over the past year.

About the Company

FoundedEmployeesCEOWebsite
20184,873Ben Wolinwww.covetrus.com

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners.

Covetrus, Inc. Fundamentals Summary

How do Covetrus's earnings and revenue compare to its market cap?
CVET fundamental statistics
Market capUS$2.94b
Earnings (TTM)-US$13.00m
Revenue (TTM)US$4.65b

0.6x

P/S Ratio

-226.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CVET income statement (TTM)
RevenueUS$4.65b
Cost of RevenueUS$3.77b
Gross ProfitUS$882.00m
Other ExpensesUS$895.00m
Earnings-US$13.00m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.093
Gross Margin18.97%
Net Profit Margin-0.28%
Debt/Equity Ratio68.7%

How did CVET perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/10/16 22:12
End of Day Share Price 2022/10/12 00:00
Earnings2022/06/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Covetrus, Inc. is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullArgus Research Company
Robert EichCleveland Research Company
Erin Wilson WrightCredit Suisse